Order Article Reprints

Xu W, Niu Y, Ai X, Xia C, Geng P, Zhu H, Zhou W, Huang H, Shi X. Liver-Targeted Nanoparticles Facilitate the Bioavailability and Anti-HBV Efficacy of Baicalin In Vitro and In Vivo. Biomedicines. 2022; 10(4):900. https://doi.org/10.3390/biomedicines10040900

Xu, Weiming, Yijun Niu, Xin Ai, Chengjie Xia, Ping Geng, Haiyan Zhu, Wei Zhou, Hai Huang, and Xunlong Shi. 2022. "Liver-Targeted Nanoparticles Facilitate the Bioavailability and Anti-HBV Efficacy of Baicalin In Vitro and In Vivo" Biomedicines 10, no. 4: 900. https://doi.org/10.3390/biomedicines10040900

Xu, W., Niu, Y., Ai, X., Xia, C., Geng, P., Zhu, H., Zhou, W., Huang, H., & Shi, X. (2022). Liver-Targeted Nanoparticles Facilitate the Bioavailability and Anti-HBV Efficacy of Baicalin In Vitro and In Vivo. Biomedicines, 10(4), 900. https://doi.org/10.3390/biomedicines10040900